x
Filter:
Filters applied
- Reviews
- Research ArticleRemove Research Article filter
Publication Date
Please choose a date range between 2006 and 2019.
Author
- Alvaro, Domenico2
- Annese, Vito2
- Cottone, Mario2
- Abrahamsson, H1
- Adinolfi, LE1
- Almasio, Piero L1
- Amodio, P1
- Andreone, P1
- Angeli, P1
- Antonaci, S1
- Aparicio, Thomas1
- Arcidiacono, Paolo Giorgio1
- Ardizzone, Sandro1
- Armuzzi, Alessandro1
- Babudieri, Sergio1
- Bain, Murray D1
- Barbarini, Giorgio1
- Baroni, G Svegliati-1
- Bax, Bridget E1
- Bellentani, S1
- Berger, Anne1
- Bernardi, M1
- Biancardi, A1
- Bianco, Margherita1
- Biancone, Livia1
Keyword
- Cirrhosis3
- Diagnosis3
- Alcohol2
- HBV2
- HCV2
- Acquired resistance1
- Alkaline phosphatase1
- Antibiotic1
- Antibiotics1
- Antiviral therapy1
- Barrett's esophagus1
- BE1
- Beclomethasone dipropionate1
- Biologics1
- Biomarkers1
- Budesonide1
- Chemotherapy1
- Cholangiocellular carcinoma1
- Chronic hepatitis1
- Cognitive impairment1
- Colitis1
- Colon cancer screening1
- Colonoscopy1
- Cramps1
- Crohn's disease1
Reviews
25 Results
- Liver, Pancreas and Biliary Tract
Brain involvement in non-alcoholic fatty liver disease (NAFLD): A systematic review
Digestive and Liver DiseaseVol. 51Issue 9p1214–1222Published online: June 6, 2019- Rosa Lombardi
- Silvia Fargion
- Anna Ludovica Fracanzani
Cited in Scopus: 31Non-alcoholic fatty liver disease (NAFLD) is associated with high cardiovascular morbidity and mortality which usually is considered to be related to cardiac involvement, while scarce attention is addressed to brain damage. Viceversa NAFLD is associated with asymptomatic brain lesions, alterations in cerebral perfusion and activity, cognitive impairment and brain aging and with increased risk and severity of both ischemic and haemorrhagic stroke. Besides known metabolic risk factors, NAFLD is characterized by a pro inflammatory state, which contributes to atherosclerosis and microglia activation, endothelial dysfunction, pro-coagulant state and platelets activation, which in turn promote both micro and macrovascular damage eventually responsible for clinical and subclinical cerebrovascular alterations. - Special ArticleOpen Access
Primary Biliary Cholangitis: advances in management and treatment of the disease
Digestive and Liver DiseaseVol. 49Issue 8p841–846Published online: May 8, 2017- Pietro Invernizzi
- Annarosa Floreani
- Marco Carbone
- Marco Marzioni
- Antonio Craxi
- Luigi Muratori
- and others
Cited in Scopus: 20Primary Biliary Cholangitis, previously known as Primary Biliary Cirrhosis, is a rare disease, which mainly affects women in their fifth to seventh decades of life. It is a chronic autoimmune disease characterized by a progressive damage of interlobular bile ducts leading to ductopenia, chronic cholestasis and bile acids retention. Even if the disease usually presents a long asymptomatic phase and a slow progression, in many patients it may progress faster toward cirrhosis and its complications. - Liver, Pancreas and Biliary Tract
Meta-analysis of the impact of SPINK1 p.N34S gene variation in Caucasic patients with chronic pancreatitis. An update
Digestive and Liver DiseaseVol. 49Issue 8p847–853Published online: May 6, 2017- Milena Di Leo
- Margherita Bianco
- Raffaella Alessia Zuppardo
- Mario Guslandi
- Federica Calabrese
- Alessandro Mannucci
- and others
Cited in Scopus: 16SPINK1 p.N34S gene variation is one of the endogenous factors which seem to be associated with chronic pancreatitis (CP). However, in literature there is no clear agreement regarding its contribution in different ethnicity and CP etiologies. - Position Paper
AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions
Digestive and Liver DiseaseVol. 49Issue 5p471–483Published online: January 23, 2017- The Italian Association for the Study of the Liver (AISF)
Cited in Scopus: 210This review summarizes our current understanding of nonalcoholic fatty liver disease (NAFLD), a multi-factorial systemic disease resulting from a complex interaction between a specific genetic background and multiple environmental/metabolic “hits”. The role of gut microbiota, lipotoxicity, inflammation and their molecular pathways is reviewed in-depth. We also discuss the epidemiology and natural history of NAFLD by pinpointing the remarkably high prevalence of NAFLD worldwide and its inherent systemic complications: hepatic (steatohepatitis, advanced fibrosis and cirrhosis), cardio-metabolic (cardiovascular disease, cardiomyopathy, arrhythmias and type 2 diabetes) and neoplastic (primary liver cancers and extra-hepatic cancers). - Alimentary Tract
The molecular landscape of colitis-associated carcinogenesis
Digestive and Liver DiseaseVol. 49Issue 4p326–330Published online: December 22, 2016- Deborah Saraggi
- Matteo Fassan
- Claudia Mescoli
- Marco Scarpa
- Nicola Valeri
- Andrea Michielan
- and others
Cited in Scopus: 30In spite of the well-established histopathological phenotyping of IBD-associated preneoplastic and neoplastic lesions, their molecular landscape remains to be fully elucidated. Several studies have pinpointed the initiating role of longstanding/relapsing inflammatory insult on the intestinal mucosa, with the activation of different pro-inflammatory cytokines (TNF-α, IL-6, IL-10, IFN-γ), chemokines and metabolites of arachidonic acid resulting in the activation of key transcription factors such as NF-κB. - Progress ReportOpen Access
Unexplained gastrointestinal symptoms: Think mitochondrial disease
Digestive and Liver DiseaseVol. 46Issue 1p1–8Published online: June 17, 2013- Thomas P. Chapman
- Gina Hadley
- Carl Fratter
- Sue N. Cullen
- Bridget E. Bax
- Murray D. Bain
- and others
Cited in Scopus: 24Defects in mitochondrial function are increasingly recognised as central to the pathogenesis of many diseases, both inherited and acquired. Many of these mitochondrial defects arise from abnormalities in mitochondrial DNA and can result in multisystem disease, with gastrointestinal involvement common. Moreover, mitochondrial disease may present with a range of non-specific symptoms, and thus can be easily misdiagnosed, or even considered to be non-organic. We describe the clinical, histopathological and genetic findings of six patients from three families with gastrointestinal manifestations of mitochondrial disease. - Progress Report
Different Antibiotic No Culture Eradicating (DANCE) strategy: An easy way to manage H. pylori eradication
Digestive and Liver DiseaseVol. 44Issue 11p889–892Published online: June 29, 2012- Davide Roccarina
- Francesco Franceschi
- Maria Assunta Zocco
- Matteo Garcovich
- Giovanni Gasbarrini
- Antonio Gasbarrini
Cited in Scopus: 9Treatment of Helicobacter pylori infection is becoming a very relevant problem especially in industrialized Countries. Although different therapeutic regimens are currently available, treatment failure remains a growing problem in daily medical practice. Several factors could play a role in the eradication failure, but the most relevant are antibiotic resistance and patient's compliance. While Helicobacter pylori resistance to amoxicillin is rare, clarithromycin and metronidazole resistance varies significantly from close to zero up to 25%. - Progress Report
Management of gastrointestinal stromal tumours of limited size: Proposals from a French panel of physicians
Digestive and Liver DiseaseVol. 43Issue 12p935–939Published online: May 30, 2011- Bruno Landi
- Olivier Bouché
- Rosine Guimbaud
- Thomas Aparicio
- Anne Berger
- Sylvie Bonvalot
- and others
Cited in Scopus: 5A number of guidelines on the management of gastro-intestinal stromal tumours (GISTs) have been published, mostly based on expert consensus. However, these guidelines have generally failed to address the specific problem of GISTs of limited size (i.e. those measuring a few centimetres in diameter) with which gastroenterologists are increasingly confronted. The aim of the present work was to draw up proposals for the diagnosis and treatment of GISTs measuring less than 5 cm in diameter. For this purpose, a number of practical questions were put to a panel of French experts. - Progress Report
Recommendations for the prevention, diagnosis, and treatment of chronic hepatitis B and C in special population groups (migrants, intravenous drug users and prison inmates)
Digestive and Liver DiseaseVol. 43Issue 8p589–595Published online: January 24, 2011- Piero L. Almasio
- Sergio Babudieri
- Giorgio Barbarini
- Maurizia Brunetto
- Dario Conte
- Pietro Dentico
- and others
Cited in Scopus: 43The global spread of hepatitis B virus (HBV) and hepatitis C virus (HCV), their high chronicity rates and their progression to cirrhosis and hepatocellular carcinoma, are major public health problems. Research and intervention programmes for special population groups are needed in order to assess their infection risk and set up suitable prevention and control strategies. Aim of this paper is to give health care professionals information on HBV and HCV infections amongst migrants, drug users and prison inmates. - Alimentary Tract
Beclomethasone dipropionate in Crohn's ileitis: A randomised, double-blind trial
Digestive and Liver DiseaseVol. 43Issue 6p459–464Published online: January 7, 2011- Cosimo Prantera
- Marina Rizzi
- Mario Cottone
- Angelo Casa
- Vito Annese
- Giacomo Carlo Sturniolo
- and others
Cited in Scopus: 11Steroids, the mainstay of Crohn's disease treatment, have been associated with systemic side effects. - Progress Report
The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guidelines: The use of tumor necrosis factor-alpha antagonist therapy in Inflammatory Bowel Disease
Digestive and Liver DiseaseVol. 43Issue 1p1–20Published online: September 15, 2010- Ambrogio Orlando
- Alessandro Armuzzi
- Claudio Papi
- Vito Annese
- Sandro Ardizzone
- Livia Biancone
- and others
Cited in Scopus: 124Biological therapies are an important step in the management of Inflammatory Bowel Diseases. In consideration of high cost and safety issues there is the need to have clear recommendations for their use. Despite the American Gastroenterological Association and the European Crohn's and Colitis Organisation have published exhaustive Inflammatory Bowel Disease guidelines, national guidelines may be necessary as cultural values, economical and legal issues may differ between countries. For these reasons the Italian Society of Gastroenterology and the Italian Group for the study of Inflammatory Bowel Disease have decided to elaborate the Italian guidelines on the use of biologics in Inflammatory Bowel Disease. - Progress Report
Cholangiocarcinoma: A position paper by the Italian Society of Gastroenterology (SIGE), the Italian Association of Hospital Gastroenterology (AIGO), the Italian Association of Medical Oncology (AIOM) and the Italian Association of Oncological Radiotherapy (AIRO)
Digestive and Liver DiseaseVol. 42Issue 12p831–838Published online: August 12, 2010- Domenico Alvaro
- Renato Cannizzaro
- Roberto Labianca
- Francesca Valvo
- Fabio Farinati
Cited in Scopus: 28The incidence of Cholangiocellular carcinoma (CCA) is increasing, due to a sharp increase of the intra-hepatic form. Evidence-ascertained risk factors for CCA are primary sclerosing cholangitis, Opistorchis viverrini infection, Caroli disease, congenital choledocal cist, Vater ampulla adenoma, bile duct adenoma and intra-hepatic lithiasis. Obesity, diabetes, smoking, abnormal biliary-pancreatic junction, bilio-enteric surgery, and viral cirrhosis are emerging risk factors, but their role still needs to be validated. - Progress Report
Familial pancreatic cancer in Italy. Risk assessment, screening programs and clinical approach: A position paper from the Italian Registry
Digestive and Liver DiseaseVol. 42Issue 9p597–605Published online: June 3, 2010- Marco Del Chiaro
- Alessandro Zerbi
- Gabriele Capurso
- Giuseppe Zamboni
- Patrick Maisonneuve
- Silvano Presciuttini
- and others
Cited in Scopus: 32In Italy, pancreatic cancer is the fifth leading cause of tumor related death with about 7000 new cases per year and a mortality rate of 95%. In a recent prospective epidemiological study on the Italian population, a family history was found in about 10% of patients suffering from a ductal adenocarcinoma of the pancreas (PDAC). A position paper from the Italian Registry for Familial Pancreatic Cancer was made to manage these high-risk individuals. Even though in the majority of high-risk individuals a genetic test to identify familial predisposition is not available, a screening protocol seems to be reasonable for subjects who have a >10-fold greater risk for the development of PDAC. - Progress Report
Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease: A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee
Digestive and Liver DiseaseVol. 42Issue 4p272–282Published online: February 22, 2010- P. Loria
- L.E. Adinolfi
- S. Bellentani
- E. Bugianesi
- A. Grieco
- S. Fargion
- and others
Cited in Scopus: 190We report the evidence-based Italian Association for the Study of Liver guidelines for the appropriate diagnosis and management of patients with nonalcoholic fatty liver disease in clinical practice and its related research agenda. The prevalence of nonalcoholic fatty liver disease varies according to age, gender and ethnicity. In the general population, the prevalence of nonalcoholic fatty liver disease is about 25% and the incidence is of two new cases/100 people/year. 2–3% of individuals in the general population will suffer from nonalcoholic steatohepatitis. - Review article
Bowel preparation before colonoscopy in the era of mass screening for colo-rectal cancer: A practical approach
Digestive and Liver DiseaseVol. 41Issue 2p87–95Published online: July 28, 2008- F. Parente
- B. Marino
- C. Crosta
Cited in Scopus: 45Colonoscopy constitutes the principal investigation for colo-rectal neoplasms due to its ability to detect and remove most of precancerous lesions; due to the ongoing or planned colon cancer screening programs in many European countries we should expect an enormous increase in colonoscopic demand over the next few years. Diagnostic accuracy and therapeutic safety of colonoscopy strictly depends upon the quality of bowel cleansing which is often perceived as the most unpleasant part of the procedure in individuals undergoing this examination. - Progress Report
Alcohol and viral hepatitis: A mini-review
Digestive and Liver DiseaseVol. 41Issue 1p67–70Published online: July 4, 2008- S. Gitto
- L. Micco
- F. Conti
- P. Andreone
- M. Bernardi
Cited in Scopus: 45Due to their high prevalence in the general population, alcohol use and abuse can be associated with hepatitis B and C virus infections and it has been demonstrated that alcohol plays a role as a co-morbid factor in the development of liver disease. There is evidence that alcohol abuse accelerates the progression of liver fibrosis and affects the survival of patients with chronic hepatitis C. The mechanism by which alcohol worsens hepatitis C virus-related liver disease has not been fully clarified, but enhanced viral replication, increased oxidative stress, cytotoxicity and impairment of immune response could play a relevant role. - Progress Report
Treatment of chronic hepatitis B: Recommendations from an Italian workshop
Digestive and Liver DiseaseVol. 40Issue 8p603–617Published online: May 23, 2008- G. Carosi
- M. Rizzetto
Cited in Scopus: 57The changing scenario of hepatitis B virus therapy has encouraged the organisation of a workshop, endorsed by three Italian scientific societies, aimed at defining the current recommendations for hepatitis B virus treatment. Liver histology and stage of disease remain fundamental for treatment decisions; interferon and nucleoside/nucleotide analogues-based therapy represent different strategies for different phases of the hepatitis B virus disease. The recommendations defined: new and lower cut-off of hepatitis B virus–DNA for eligibility to therapy according to disease stage, how to optimise the use of nucleoside/nucleotide analogues and to individualise the monitoring of response and what to do with treatment failures. - Digestive Endoscopy
Reprocessing in digestive endoscopy units in Lombardy: Results of a regional survey
Digestive and Liver DiseaseVol. 40Issue 11p890–896Published online: April 10, 2008- G. Spinzi
- R. Fasoli
- R. Centenaro
- G. Minoli
- The SIED Lombardia Working Group
Cited in Scopus: 8Inadequate disinfection of endoscopes and associated instrumentation can result in transmission of infections to patients. The aim of this study is to assess cleaning and disinfection practice in gastrointestinal endoscopy units in public and private institutions in the Lombardy region. - Viewpoint
Muscle cramps in cirrhosis: The therapeutic value of quinine. Is it underused?
Digestive and Liver DiseaseVol. 40Issue 9p794–799Published online: March 25, 2008- A. Corbani
- P. Manousou
- V. Calvaruso
- I. Xirouchakis
- A.K. Burroughs
Cited in Scopus: 12Muscle cramps are a common and recurring symptom in patients with cirrhosis. Although, the pathophysiology has not been specifically studied in cirrhosis, this is thought to be the same for cramps in general, originating in the motorneurone, with high frequency firing of motor unit action potentials. However precise pathophysiological mechanisms are not known. Risk factors in cirrhosis have been little studied. Neither aetiology, nor pre-ascitic or ascitic stage, nor electrolyte disturbances, nor use of diuretic therapy has been found to have a statistical association with cramps in patients with cirrhosis. - Liver, Pancreas and Biliary Tract
Neurological complications after orthotopic liver transplantation
Digestive and Liver DiseaseVol. 39Issue 8p740–747Published in issue: August, 2007- P. Amodio
- A. Biancardi
- S. Montagnese
- P. Angeli
- P. Iannizzi
- U. Cillo
- and others
Cited in Scopus: 67The number of orthotopic liver transplantation performed each year is increasing due to increased safety and logistic facilities. Therefore, the importance of reducing adverse events is progressively growing. - Viewpoint
Gastroesophageal reflux disease is a progressive disease
Digestive and Liver DiseaseVol. 39Issue 5p409–414Published in issue: May, 2007- F. Pace
- S. Pallotta
- N. Vakil
Cited in Scopus: 23It is controversial whether gastrooesophageal reflux disease represents a spectrum disease from a nonerosive to a complicated one, or whether it is a categorial disease, i.e. it can be divided into three categories, such as nonerosive gastrooesophageal reflux disease, erosive gastrooesophageal reflux disease and Barrett's esophagus (BE) with little or no transition from one category to the other. This controversy might be of general interest, because it has some implications in the management of the patient. - Progress Report
Nutritional aspects in patients with functional gastrointestinal disorders and motor dysfunction in the gut: Working team report of the Swedish Motility Group (SMoG)
Digestive and Liver DiseaseVol. 39Issue 5p495–504Published in issue: May, 2007- M. Simrén
- H. Abrahamsson
- I. Bosaeus
- R.J. Brummer
- A. Dolk
- G. Lindberg
- and others
Cited in Scopus: 10In reviews regarding the management of patients with functional gastrointestinal disorders and motility disturbances within the gut nutritional aspects and dietary advice is often put forward as being of great importance. However, there are relatively few high-quality, interventional studies in the literature supporting an important role for general dietary advice to improve symptoms in these patients. Nutritional supplementation to patients with malnutrition due to severe dysfunction of the gastrointestinal tract is of course less controversial, even though different views on how this should be performed exist. - Progress Report
Push-and-pull enteroscopy using the double-balloon technique/double-balloon enteroscopy
Digestive and Liver DiseaseVol. 38Issue 12p932–938Published in issue: December, 2006- A. May
- C. Ell
Cited in Scopus: 41Push-and-Pull enteroscopy/Double balloon enteroscopy (PPE/DBE) allows enteroscopy of the entire small bowel, or at least a substantial part of it. The complication rate is acceptably low. Severe complications such as pancreatitis and perforation were encountered in the literature in approximately 1% of all diagnostic PPE/DBEs. It can be expected that the complication rate of therapeutic PPE/DBEs is higher, comparable with the conventional endoscopy. The diagnostic yield is high, at approximately 75%, as is the therapeutic yield. - Research Article
Antibiotic resistance: the pros and cons of probiotics
Digestive and Liver DiseaseVol. 38SupplementS261–S265Published in issue: December, 2006- Patrice Courvalin
Cited in Scopus: 74For the prevention of intestinal disorders, probiotics can be rendered multidrug resistant to survive in the presence of co-administered antibiotics. This generates the possibility of resistance transfer from the probiotic to human bacterial pathogens, either directly or indirectly via the commensal flora. This article reviews the experiments to be performed and the criteria for assessment of safety of antibiotic resistant probiotics. - Progress Report
New frontiers in biomarkers for hepatocellular carcinoma
Digestive and Liver DiseaseVol. 38Issue 11p854–859Published in issue: November, 2006- G. Giannelli
- S. Antonaci
Cited in Scopus: 30Hepatocellular carcinoma represents the fifth most frequent cancer in the world; it commonly occurs on cirrhotic liver. Prognosis and survival are still poor, mainly because of diagnosis at a late stage and/or recurrence of the disease. For this reason, surveillance strategies are widely used to screen for early occurrence of cancer in populations at risk. Alpha-foetoprotein is so far the only serological marker available, but its diagnostic accuracy is unsatisfactory because of low sensitivity despite reliable specificity.